NCT05157139

Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease

• Status: Unknown
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Alexandria University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

* The study is a randomized clinical trial to assess a natural formula of vanillin \& wheat germ oil to treat and stop the clinical progression of COVID-19. * The study aims to treat people with mild-to-moderate COVID-19 before their cases become severe. * The study duration is a 5-day experimental intervention and an extended 4 weeks follow up.

Conditions

• Mild-to-moderate COVID-19

Interventions

Type	Name	Description
DRUG	Oral Capsule	Oral Capsule of vanillin \& wheat germ oil

Timeline

• Start date: 2021-11-01
• Primary completion: 2022-03-01
• Completion: 2022-04-01
• First posted: 2021-12-14
• Last updated: 2022-01-31

Locations

1 site across 1 country: Egypt